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Recently, we have shown that the age-specific prevalence of a disease can
be related to the transition rates in the illness-death model via a partial
differential equation (PDE). In case of a chronic disease, we show that the
PDE can be used to estimate excess mortality from prevalence and incidence.
Applicability of the new method is demonstrated in a simulation and claims
data about diabetes in German men.
Introduction
Recently, we have shown that the age-specific prevalence of a health state or disease
can be related to the transition rates in the illness-death model (IDM) via a partial
differential equation (PDE) [2, 3]. In case of a chronic disease, this relation can be used
to estimate the incidence from a sequence of cross-sectional studies if information about
mortality is available [4, 1].
In this paper, we demonstrate that it is also possible to estimate excess mortality from
prevalence and incidence of a chronic disease, which can be useful for the analysis of data
from disease registers or health insurance claims. For this, we examine the relations of
the illness-death model and associated PDEs. In this context, we derive a new PDE
which generalises the PDE of Brunet and Struchiner [6]. In a simulation study, the
new PDE is used to demonstrate how the excess mortality can be estimated directly.
Furthermore, we present an estimation method in the framework of Bayesian statistics.
In an application of the Bayesian approach, we estimate the excess mortality of diabetes
from claims data comprising 70 million Germans.
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Illness-death model and associated partial differential
equations
We consider the illness-death model for chronic (i.e., irreversible) diseases shown in
Figure 1. The considered population is split into the relevant disease states Healthy
(H) and Ill (I). From either states people can transit into the state Dead (D). The
transition rates between the three states are the incidence rate (i), the mortality rate of
the healthy (m0) and the mortality rate of the diseased (m1). These rates depend on
the calendar time t and on the age a. Additionally, the mortality rate m1 depends on
the duration d of the disease.
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Figure 1: The transition rates i,m0,m1 between the compartments H (healthy), I (ill),
and D (dead) in the illness-death model depend on calendar time t and age a.
The mortality rate m1 additionally depends on the duration d of the disease.
Let the numbers H and I denote the numbers of people in the respective states. To
be more specific, H(t, a) is the number of healthy people aged a, a ≥ 0, at time t; and
I(t, a, d) is the number of diseased people aged a, a ≥ 0, at t who are diseased for the
duration d, d ≥ 0. We assume that the considered population is sufficiently large that
H and I can be considered as smooth functions. The total number of subjects aged a
at t who have the chronic disease is I?(t, a) =
∫ a
0
I(t, a, δ) dδ.
Let us furthermore assume that the considered population is closed, i.e., there is no
migration and that the disease is contracted after birth. The later assumption implies
I?(t, 0) = 0 for all t. Then, we can formulate following equations for the change rates of
H and I:
(∂t + ∂a)H(t, a) = −
(
m0(t, a) + i(t, a)
)
H(t, a)(1)
(∂t + ∂a + ∂d) I(t, a, d) = −m1(t, a, d) I(t, a, d),(2)
where ∂x means the partial derivative with respect to x, i.e., ∂x =
∂
∂x
for x ∈ {t, a, d}.
In addition to the PDEs (1) – (2)), which describe the outflows from the states Healthy
and Ill, we need the following initial conditions:
H(t− a, 0) = H0(t− a).
I(t, a, 0) = i(t, a)H(t, a).
2
The first initial condition represents the number of (disease-free) newborns H0, and the
second initial condition describes the number of newly diseased persons, the incident
cases.
In [4], we have shown that the age-specific prevalence p(t, a) = I
?(t,a)
I?(t,a)+H(t,a)
is the solution
of a scalar PDE that can be derived from the two-dimensional system (1) – (2). Here, we
choose a different approach. Instead of considering the age-specific prevalence p(t, a), we
follow the idea of Brunet and Struchiner and examine the prevalence-odds pi(t, a) = I
?(t,a)
H(t,a)
[6]. Using the terminology ∂ = ∂t + ∂a, we obtain
∂pi =
∂I?
H
+ pi (i+m0)
=
−m?1 I? + iH
H
+ pi (i+m0)
= i+ pi (i+m0 −m?1) .
For the second equality we used ∂I? = −m?1 I? + iH, which has been proven in the
Appendix of [4]. The rate m?1 is defined as
(3) m?1(t, a) :=

a∫
0
m1(t,a,δ) I(t,a,δ)dδ
a∫
0
I(t,a,δ)dδ
for I?(t, a) > 0
0 for I?(t, a) = 0.
Remark: The rate m?1 may be accessible in epidemiological surveys by choosing a sam-
ple population with representative distribution of disease duration. However, in most
practical cases, it is unknown because the distribution I(t,a,d)∫ a
0 I(t,a,δ)dδ
in Eq. (3) is not known.
Thus, we obtain following linear scalar PDE
(4) ∂pi = i− pi (i+m0 −m?1) ,
which shows how the temporal change of the prevalence-odds ∂pi is governed by the rates
in the illness-death model in Figure 1 and the value of the prevalence-odds itself.
Remark: If m1 does not depend on the duration d, we have m?1 = m1 and Eq. (4) is
equivalent to the PDE (3) in Brunet and Struchiner [6]. Hence, Eq. (4) is a generalisation
of the PDE of Brunet and Struchiner.
Remark: Eq. (4) is equivalent to
(5) ∂p = (1− p) (i− p (m?1 −m0)),
which has been proven in [4]. With the definition R =
m?1
m0
and letting m be the overall
mortality, m = pm?1 + (1− p)m0, then Eq. (5) becomes
(6) ∂p = (1− p)
(
i−m p (R− 1)
1 + p (R− 1)
)
.
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For our purpose of estimating the excess mortality ∆m = m?1 − m0, Eq. (4) is very
useful, because it holds
(7) ∆m =
i (1 + pi)− ∂pi
pi
.
An advantage of the approach of Brunet and Struchiner lies in an explicit representation
of the prevalence-odds in case the rates i,m0 and m1 are given. Then starting from Eq.
(1) – (2) combined with the initial conditions of above, we obtain following equation by
using calculus:
pi(t, a) =
a∫
0
i(t− δ, a− δ)×
(8)
exp
− δ∫
0
{m1(t− δ + τ, a− δ + τ, τ)− (i+m0) (t− δ + τ, a− δ + τ)} dτ
 dδ.
With pi = p
1−p , we see that Eq. (8) is a generalisation of Eq. (1) in [3]. One advantage
of the explicit representation of pi in (8) is the possibility to (numerically) calculate
pi with a prescribed accuracy, e.g. by Romberg integration [8], which we will use in
the examples below. Numerical solutions of differential equations usually do not allow
prescribed levels of accuracy.
Examples and demonstration
Direct estimation of excess mortality
The first example is about a hypothetical chronic disease with all time-scales t, a and d
playing a role. The incidence of the chronic disease is assumed to be i(t, a) = (a−30)+
3000
,
which implies that the disease affects only people aged 30 and older. The age-specific
mortality rate of the non-diseased is chosen to bem0(t, a) = exp(−10.7+0.1a+t ln(0.98)).
In addition, we assume that the mortality m1 of the diseased can be written as a product
of m0 and a factor that depends only on the duration d:
m1(t, a, d) = m0(t, a)× (0.04(d− 5)2 + 1).
Except for the time trend in m0, this example is the same as Simulation 2 in [5].
For the example, we mimic the situation that we have three cross-sectional studies in
the years t0 = 95, t1 = 100, and t2 = 105. We calculate the prevalence odds pi for these
years via Eq. (8). Figure 2 shows the prevalence-odds for the three years. Until age of
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Figure 2: Prevalence odds of the hypothetical chronic disease in the years t = 95 (red),
t = 100 (green), and t = 105 (blue).
about 70 years, the three prevalence-odds are virtually the same. For our example, we
additonally assume that we have the age-specific incidence rate available for the year
t1 = 100. The aim is to estimate the excess mortality in t1.
The proposed method to estimate the excess mortality ∆m in the year t1 = 100 is direct
application of Eq. (7). As assumed the incidence i for t1 = 100 is assumed to be given.
The partial derivative ∂pi is approximated by following finite difference:
∂pi(t1, a)
.
= 1
t2−t0
[
pi(t2, a+
t2−t0
2
)− pi(t0, a− t2−t02 )
]
.
Then, we the excess mortality ∆m can be estimated by plugging these numbers into Eq.
(7). In case the mortality rate m0 of the non-diseased is known, ∆m is often expressed
in terms of the hazard ratio R =
m?1
m0
which can be obtained from
R = 1 +
∆m
m0
.
The age-specific HR expresses the mortality rate of the diseased people relative to the
non-diseased at the same age. For the hypothetical chronic disease we find the age-
specific HR as in Figure 3. The age-specific HR is peaking between age a = 70 and
a = 80 and falling with increasing age.
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Figure 3: Age-specific hazard ratio R =
m?1
m0
in the year t = 100.
In case, the mortality rate m0 of the non-diseased population is not known, ∆m can
also be compared to the mortality rate m of the general population. It holds m =
(1− p)m0 + pm?1 = 11+pi m0 + pi1+pi m?1. Usually, the mortality of the general population
is accessible from vital statistics of the federal statistical offices.
Bayes estimation of excess mortality
The second example is about claims data from Germany during the years 2009 to 2015.
Goffrier and colleagues reported the age-specific prevalence of diabetes of German men
in the years t0 = 2009 and t1 = 2015 as shown in Figure 4, [9].
Based on the incidence rate (i) in 2012 (reported in Table 5 of [9]), our aim is to estimate
the age-specific hazard ratio R(a) for the same year. For this, we use a Bayes approach.
Motivated by empirical findings from the Danish diabetes register, we assume that the
logarithm of the age-specific HR R approximately is a straight line in the age range 50
to 90 years of age (see Figure 5 in [7]). Thus, we make the approach
lnR(a) = lnR(50) +
lnR(90)− lnR(50)
90− 50 × a.
For R(50) and R(90) we use weakly informative prior distributions R(50) ∼ U(1.5, 4)
and R(90) ∼ U(1, 2.5), where U means the uniform distribution. In Bayes terminology,
our aim is to estimate a-posteriori distributions for R(50) and R(90).
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Figure 4: Age-specific prevalence of diabetes in German men in 2009 (black) and 2015
(blue).
This done by randomly drawing R(50) and R(90) from the prior distributions, solving
the PDE (6) with initial condition p(2009, a). For solving the PDE, we use the Method
of Characteristics [11] to convert Eq. (6) into an ordinary differential equation (ODE)
and then solve the ODE by the Runge-Kutta Method of fourth order [8]. The calculated
prevalence in 2015, p(2015, a), is then compared with the observed prevalence in 2015
as shown as blue line in Figure 4. Instead of the joint a-posteriori distribution, the
log-likelihood of the deviation between observed and calculated prevalence is computed.
The results are shown in Figure 5. The black cross indicates the maximum a-posteriori
(MAP) estimator for these data, which is given by RMAP(50) = 2.19 and RMAP(90) =
1.46.
Discussion
In this work, we have described how the illness-death model can be used to obtain
information about mortality in case prevalence and incidence are given. This allows
insights into the excess mortality of people with chronic diseases compared to the people
without the disease or the general population.
We presented two methods of estimating excess mortality, one direct estimation method
and one method in the context of Bayesian statistics. The methods can be used if
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Figure 5: A posteriori distribution of R(50) and R(90) with maximum a-posteriori esti-
mator (black cross).
prevalence and incidence of chronic disease are given, e.g. in claims data [9] or in the
setting of disease registers [10].
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